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In Africa, diarrhoea accounts for up to 75% of all illnesses in children aged five years or 
younger. In KwaZulu-Natal scanty data exists on the prevalence of intestinal parasites 
causing diarrhoea in this age group. Cryptosporidium parvum, Entamoeba histolytica and 
Giardia lambliae are the most common pathogens known to cause diarrhoea in children. 
Approval to conduct this study was obtained from the University of KwaZulu-Natal’s 
Biomedical Research Ethics Committee. Informed consent was obtained from parents or 
other caregivers. Stool specimens of 251 children were collected and preserved in 5% 
formalin. Faecal smears were prepared for microscopic examination and stained using the 
modified Ziehl-Neelsen stain and the modified Ryan-Blue trichrome stain. The modified 
Ziehl-Neelsen stain detected G. lambliae in 1% of the children and C. parvum in 15%. 
With the modified trichrome stain these numbers changed to 2.5% and 7% respectively. 
When the results of both staining techniques were combined the prevalence increased to 
3% for G. lambliae and 21% for C. parvum. Our results show that diarrhoea amongst the 
population under investigation is mainly caused by C. parvum. PCR to confirm the number 
of G. lamblia and C. parvum obtained by microscopy was unsuccessful. Various DNA 
extraction methods were tried. The lack of success is likely the result of the resistance of 
the cyst wall to chemicals and temperature changes. This warrants further investigations. 
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In Africa, diarrhoea accounts for up to 75% of all illnesses in children aged five years or 
younger. In KwaZulu-Natal scanty data exists on the prevalence of intestinal parasites 
causing diarrhoea in this age group. Cryptosporidium parvum, Entamoeba histolytica and 
Giardia lambliae are the most common pathogens known to cause diarrhoea in children. 
Approval to conduct this study was obtained from the University of KwaZulu-Natal’s 
Biomedical Research Ethics Committee. Informed consent was obtained from parents or 
other caregivers. Stool specimens of 251 children were collected and preserved in 5% 
formalin. Faecal smears were prepared for microscopic examination and stained using the 
modified Ziehl-Neelsen stain and the modified Ryan-Blue trichrome stain. The modified 
Ziehl-Neelsen stain detected G. lambliae in 1% of the children and C. parvum in 15%. 
With the modified trichrome stain these numbers changed to 2.5% and 7% respectively. 
When the results of both staining techniques were combined the prevalence increased to 
3% for G. lambliae and 21% for C. parvum. Our results show that diarrhoea amongst the 
population under investigation is mainly caused by C. parvum. PCR to confirm the number 
of G. lamblia and C. parvum obtained by microscopy was unsuccessful. Various DNA 
extraction methods were tried. The lack of success is likely the result of the resistance of 
the cyst wall to chemicals and temperature changes. This warrants further investigations. 
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Chapter One: Introduction 
Parasitism is a relationship between species where one species the parasite, benefits at the 
expense of the other, the host. This is not restricted to any group of organisms. However, 
historically the term “parasitology” has been used for the science that deals with helminths 
and protozoa. In this dissertation the term parasite refers to these two groups of organisms. 
 
Infections caused by intestinal parasites are amongst the most common infections globally 
(Nxasana et al., 2013). These include protozoal infections that cause diarrhoea. Diarrhoea 
is the leading cause of morbidity and mortality amongst children in the developing world 
(Tinuade et al., 2006).  
 
Diarrhoea is defined as the passage of three or more loose stools within a period of twenty 
four hours (WHO, 2007). Diarrhoea can be categorized based on the duration, as acute or 
persistent (chronic). If the diarrheal episodes last for less than fourteen days, it is termed 
acute diarrhoea. If the episodes last for more than fourteen days it is termed persistent 
diarrhoea (Abba et al., 2008). Such chronic diarrhoea often occurs in immune-
compromised individuals, such as patients with AIDS. 
 
In Africa, an estimated 25-75% of all illnesses in children under the age of five are due to 
diarrhoea (Kirkwood, 1991). In developing countries parasitic disease resulting in 
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diarrhoea, remains a serious health problem (Akingbade et al., 2013). Nearly 90% of 
diarrhoea is due to infections from unsafe drinking water, poor hygiene and inadequate 
sanitation (Godana and Mengistie, 2013). 
 
In developing countries the mortality rate as a result of diarrheal infections is as high as 
56% (Samie et al, 2012). Annually, diarrhoea contributes to 4.6-6 million child deaths in 
Africa, America and Asia, of which 80% occur within the first two years of life (Ali et al., 
2009).  
 
Throughout South Africa high levels of intestinal parasites have been reported. In Mthatha, 
in the Eastern Cape Province, more than 60 % of primary school children were found to 
have intestinal parasitic infections. The majority of these pupils carried multiple parasites 
(Nxasana et al., 2013). A study conducted in the Vhembe district in the Limpopo province, 
investigated the causes of diarrhoea in pupils from two schools and patients attending three 
different hospitals. They found that 78% of those with diarrhoea were children aged less 
than five years. Intestinal parasites were detected in 68% of all specimens screened, 
indicative of a high prevalence in this community (Samie et al., 2012).  
 
In KwaZulu-Natal the reported prevalence for intestinal parasites among school children 
ranged between 70 – 100% (Schutte et al., 1977, Evans et al., 1987, Taylor et al., 1995 and 
Mabaso et al., 2003). A large proportion of the infected population live in rural and peri-
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urban areas, in which there is inadequate supply of water and inadequate sanitation 
(Nxasana et al., 2013). According to South African Statistics, 22.3 % of people live in 
informal settlements, traditional dwellings or other sub-optimal living conditions, and only 
70% of the population have access to running water. In the eThekwini district of KwaZulu-
Natal, only 60.2% have access to piped water within their dwelling (Statistics South Africa, 
2008).With access to clean drinking water, implementation of flushed toilet facilities and 
practicing good hygiene, diarrhoea can be reduced significantly (Samie et al., 2009).  
 
In KwaZulu-Natal there is scanty data on the prevalence of intestinal parasites causing 
diarrhoea in children of five years of age and below. The lack of interest and expertise in 
the field of parasitology, often leads to under-diagnosis and misdiagnosis of parasitic 
infections (Mkhize-Kwitshana and Mabasa, 2012). In addition, more than one diagnostic 
test needs to be employed in order to optimise the accuracy and reduce the levels of 
misdiagnosis. This is laborious and time-consuming.   
 
As diarrhoea alone kills more children than measles, malaria and AIDS combined (Godana 
and Mengistie, 2013), the aetiology of diarrhoea and the drug susceptibility profiles of 
these causative agents, including parasites needs to be monitored. This will lead to 
strategies for planning and implementing interventions, as well as the assessment of the 
effect of these interventions (Samie et al., 2012).  
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In KwaZulu-Natal the mortality in infants in the 0-5 year age group is still high. Diarrhoea 
and respiratory tract infections are among the leading causes. This is despite the fact that 
vaccination coverage is high. This can be because microorganisms other than those 
covered by the vaccination program are causing the infections. This led us to investigate 
the aetiology of diarrhoea. This study presented here is therefore part of a bigger study. We 
aimed to determine the prevalence of intestinal parasites causing diarrhoea in children 
within the 0-5 year age group, in the eThekwini district of KZN.  Microscopic analysis 
using two staining techniques was applied to this study. PCR was applied to this study with 
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  Chapter Two: Literature Review 
2.1. Anatomy and Physiology of the Gastrointestinal Tract 
The gastrointestinal tract (GIT) starts from the mouth where food and water is ingested and 
ends at the anus where waste products are expelled. The tract is divided into the upper GIT 
which extends from the mouth to the duodenum, the middle GIT continuing from the 
duodenum to the colon and the lower GIT extending from the colon to the anus. The upper, 
middle and lower GIT is also known as the foregut, midgut and hindgut, respectively 
(Kapoor, 2016). The middle and lower GIT is made up of the small and large intestine. The 
small intestine is differentiated into three components the duodenum, ileum and jejunum 
whilst the large intestine is made up of the caecum, ascending, transverse, descending and 
sigmoid colon, as well as the rectum (Reinus and Simon, 2014).  
 
After food is ingested, it is chewed. Chewing stimulates the production of saliva which 
initiates the breakdown of food.  Food particles are then passed down the oesophagus with 
the aid of mucus and peristaltic muscular movement to reach the stomach. The stomach 
controls the rate of entry of food and serves as a temporary location for its storage. 
Preliminary digestion is facilitated by acid activated lipases and pepsin, resulting in chyme 
(Martini, 2001). In this process, microbes ingested with the food are killed in the acidic 
proteolytic mix. 
 
When chyme enters the duodenum the pH changes from acidic to alkaline due to the 
addition of bile and pancreatic enzymes (Martini, 2001). The small intestine has a length of 
8 m. Its surface area is enlarged due to the presence of villi and microvilli on the surface of 
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enterocytes (Reinus and Simon, 2014). Hence it is a site where the majority of the nutrients 
are absorbed (Carr and Toner, 1984). This is also the site where drug absorption takes 
place. The large intestine is where the absorption of water from the digested products 
occurs. Semi-solid faeces are passed to the rectum for excretion via the sphincter muscles 
of the anus (Martini, 2001). 
 
The intestine is sterile at birth. However over a period of time more than a thousand 
different species of microbes populate the intestine. These organisms are both symbionts 
and commensals that exhibit a positive interaction with the intestine of the host (Lozupone 
et al., 2012). Interactions facilitated by symbionts include digestion of nutrients and 
stimulation of the immune system. Of microbiological importance is the barrier mediated 
by symbionts, which prevents the dissemination of disease causing pathogens into other 
areas of the body that are sterile (Sekirov et al., 2010).  
 
2.2. Non-Infectious Causes of Diarrhoea 
Although diarrhoea is predominantly caused by pathogens entering the GIT, there are a few 
causes of diarrhoea that are non-infectious. For instance an incorrect diet including 
carbohydrates such as lactose may result in diarrhoea (Fan and Sellin, 2009). Another 
cause could stem from the consumption of food poisoned with harmful chemicals (Esrey, 
1990). Diarrhoea could also be a result of irritable bowel syndrome or intestinal diseases 
such as Crohn’s disease, celiac disease, ulcerative colitis and inflammatory bowel disease. 
Medication used in the treatment of cancerous cells may lead to diarrhoea; use of antacids 
of magnesium origin may also cause symptoms of diarrhoea. (National Institute of 
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Diabetes and Digestive and Kidney Diseases, 2013). Another possible cause of 
gastroenteritis could be attributed to the malabsorption of bile salts (Fan and Sellin, 2009).  
 
Broad spectrum antibiotics, such as tetracycline target both pathogens and commensals of 
the gastrointestinal tract. Eradication of the pathogen as well as the gut microflora, results 
in re-colonization by other bacteria such as Staphylococcus aureus. Such re-colonisation 
has been associated with enterocolitis and diarrhoea. Shortly after clindamycin was 
introduced as a therapeutic agent, findings demonstrated a blanket of fibrinous 
pseudomembrane covering the colonic mucosa. This resulted in severe diarrhoea. It was 
later shown that, clindamycin was not the cause. Instead clindamycin inhibited the normal 
gut flora which adversely resulted in multiplication of the clindamycin resistant 
Clostridium difficile and hence caused symptoms of diarrhoea (Goering et al., 2008). 
 
2.3. Infectious Causes of Diarrhoea 
Infectious causes of diarrhoea include bacterial, viral and protozoal pathogens. Bacterial 
infectious agents include; Campylobacter jejuni, (Probert et al., 2016) Salmonella spp., 
Shigella spp., (Mohammed, 2015) Vibrio Cholera (Rathur et al., 2014) and Clostridium 
difficile, (Probert et al., 2016). Bacterial culprits of diarrhoea also include; 
enteropathogenic, enterotoxigenic, enteroadherent as well as enterohaemorrhagic 
Escherichia coli.  (Ogunsanya et al., 1994). Other organisms like Klebisella oxytoca, 
Pseudomonas aeruginosa and Proteus spp. (Mohammed, 2015) have been associated with 
episodes of diarrhoea but their causal relationship is still up for debate. 
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Viruses such as rotavirus, norovirus, astrovirus, adenovirus and saprovirus cause 
infectious diarrhoea with a high prevalence among children under the age of five (Ren et 
al., 2013). Protozoa such as Cryptosporidium parvum, Entamoeba histolytica and Giardia 
lambliae are considered important causes of diarrhoea (Verweij et al., 2004).  
 
2.4. Entero-Pathogenic Protozoa Associated with Diarrhoea 
The differences in the degree of pathogenicity among gastrointestinal protozoa as well as 
the immune status of the infected host are illustrated in Table 2.1. Organisms are listed and 
discussed in alphabetical order. 
 
 Balantidium coli; is classified as a definite pathogen since it causes severe diarrhoea in 
immune compromised individuals by HIV infection. However, when present in the 
immune competent host Balantidium coli does not cause severe disease (Schuster and 
Ramirez-Avila, 2008).  
 
Whether Blastocystis hominis is a pathogen or not remains debatable. Therefore in Table 
2.1., it is classified as a probable pathogen. Studies however have identified a few subtypes 
(ST-1, ST-2, ST-4 and ST-8) of Blastocystis hominis associated with severe diarrhoea.  
However, additional studies could not confirm an association with pathogenicity. Higher 
detection rates of Blastocystis hominis has been associated with AIDS patients; indicating 
that immune compromised individuals may be more susceptible to this parasite (Roberts et 
al., 2013).  
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Chilomastix mesnili is often detected in stool specimens together with other pathogenic 
protozoa, but it is not considered pathogenic. It is present in symptom free, immune 
competent hosts (El-Ammari and Nair, 2015). Cyclospora cayetanensis can definitely be 
categorised as a pathogen (Table 2.1.), as it has been associated with several outbreaks 
involving both immune suppressed and immune competent people (Chawla and 
Ichhpujani, 2011). 
 
 Dientamoeba fragilis was initially described as a harmless commensal of the 
gastrointestinal tract. Recent studies show the presence of Dientamoeba fragilis in stool 
specimens of patients suffering from diarrhoea. After treatment was administered to these 
patients, Dientamoeba fragilis was eradicated. Hence it is considered a possible pathogen. 
There have been studies that have reported Dientamoeba fragilis to be more common in the 
HIV infected population, whilst other studies indicate that it is more common in non-HIV 
infected individuals (Barratt et al., 2011).  
 
Endolimax nana (Santos et al., 2014), Entamoeba coli (Rayan et al., 2010), Entamoeba 
hartmanii (Becker et al., 2011) and Iodamoeba butschili (Issa, 2014) have all been reported 
in various studies as harmless commensals in those that are immune competent. 
Entamoeba dispar is a harmless commensal present in the immune competent host and has 
not been implicated in causing disease or invading the mucosa of patients with AIDS 
(Stanley Jr., 2003).   
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Microsporidia sp, such as Enterocytozoon bieneusi are categorised as definite pathogens 
since they have been reported to cause chronic diarrhoea in HIV infected individuals and 
self-limiting acute diarrhoea, in immune competent individuals (Chawla and Ichhpujani, 
2011). In recent years, Isospora belli has emerged as an important gastrointestinal 
pathogen listed in Table 2.1 Infections with this organism is most commonly associated 
with AIDS patients and is known to cause severe diarrhoea (Mudholkar and Namey, 2010). 
Sarcocystis hominis is listed as a possible pathogen since humans act as the intermediate 
host. During this phase, the host may experience diarrhoea as a result (Chiodini et al., 
2003). 
 
Table 2.1.: Virulence and Host Immune Status Associated with Gastrointestinal 
Pathogens 
 




Association with host immune status 
Balantidium coli Definite pathogen 2 
Blastocystis hominis Probable pathogen 2 
Chilomastix mesnili Non-pathogen 1 
Cryptosporidium parvum Definite pathogen 1+2 
Cyclospora cayetanensis Definite pathogen 1+2 
Dientamoeba fragilis Possible pathogen 1+2 
Endolimax nana Non-pathogen 1 
Entamoeba coli Non-pathogen 1 
Entamoeba dispar Non-pathogen 1 
Entamoeba hartmanni Non-pathogen 1 
Entamoeba histolytica Definite pathogen 1+2 
Enterocytozoon bieneusi Definite pathogen 1+2 
Giardia lambliae Definite pathogen 1+2 
Iodamoeba butschili Non-pathogen 1 
Isospora belli Definite pathogen 2 
Sarcocystis hominis Possible pathogen 1 
1: Immune competent host, 2: Immune compromised host and 1+2: Immune competent and 
immune compromised host. 
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Cryptosporidium parvum, Entamoeba histolytica and Giardia lambliae are classified as 
definite pathogens, as shown in Table 2.1. These entero-pathogenic protozoa are associated 
with both sporadic as well as outbreak-related diarrhoea (Tigabu, 2010 and Jarmey-Swan 
et al., 2001). They are important causes of diarrhoea since they are able to infect the 
immune competent host as well as the immune suppressed host (Wellington et al., 2008, 
Leav et al., 2003). This chapter will focus mainly on the history, morphology, 
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 2.4.1. Entamoeba histolytica 
2.4.1.1. History and use as a biological weapon 
E.histolytica was initially described in 1875 by Fedor Lösh. However, it was in 1903 that 
Fritz Schaudinn named the species (Fotedar et al., 2007).  E. histolytica can be used as a 
biodefense tool. This is primarily because E. histolytica has a low infectious dose of < 10 
cysts and its cysts have the ability to withstand the effects of chlorination. These properties 
can be misused for activities such as bioterrorism and war (Barwick et al., 2002). 
 
2.4.1.2. Morphology 
E.histolytica cysts are round with a diameter of 10-15 micrometres. The wall around the 
cell is refractive and is composed of chitin. The refractive wall of the cyst is visible during 
screening and may help distinguish cysts from artefacts. The contents of the cyst include, 
four nuclei, glycogen and chromatid bodies. E.histolytica trophozoites are motile and range 
in size from 10-50 micrometres (Stanley Jr., 2003). These characteristics can be observed 
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A.)                                                                          B.)          
     
Figure 1: Entamoeba histolytica in stool                                                                             
In the first image (A), E histolytica trophozoites are stained with Wheatley’s trichrome stain 
(800 x). The nucleus and central karyosome is visible. The second image (B) shows an E 
histolytica cyst (1600 x) present in stool specimens that were stained with the chlorazol black 
stain. Two nuclei, each containing the central karyosome, are visible. Figure 1 has been 
provided by the US Centres for Disease Control and Prevention (Stanley Jr., 2003).  
 
The genus Entamoeba consists of two morphologically identical organisms, a commensal, 
Entamoeba dispar and a pathogen, Entamoeba histolytica (Fotedar et al., 2007). 
Microscopy does not distinguish Entamoeba dispar from Entamoeba histolytica and is 
therefore not suitable as a diagnostic method. Methods that can be used include ELISA and 
PCR (Stanley Jr., 2003). 
 
2.4.1.3. Symptoms and Signs of Amoebiasis 
E.histolytica is known to cause amoebiasis (Stanley Jr., 2003). Infection caused by E. 
histolytica can be asymptomatic or symptomatic. In symptomatic patients, this pathogen is 
known to cause ulcerative, invasive disease of the wall of the colon with bloody diarrhoea 
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respiratory tract, the genitourinary tract and the cerebrum (Fotedar et al., 2007). Children 
infected with E. histolytica are three times more likely to be malnourished and five times 
more likely to be stunted.  Children are therefore regarded as a vulnerable population 
(Mondal et al., 2006). 
 
2.4.1.4. Pathogenesis and Life Cycle 
E. histolytica differs from other protozoa in that it has a relatively simple life cycle, 
existing either as an infectious cyst or an amoeboid trophozoite.  After ingestion, cysts pass 
through the stomach surviving the hostile acidic environment with its aggressive digestive 
enzymes. These then travel to the small intestine, where they excyst (Stanley Jr., 2003 and 
Petri Jr et al., 2002). Eight trophozoites from each cyst are produced.  
 
Adherence of E. histolytica to the colonic mucus and intestinal epithelium of the large 
intestine is mediated by the Gal/GalNAc lectin present on the surface of trophozoites. The 
Gal/GalNAc lectin binds to carbohydrates of the host that contain Gal and / or GalNac. The 
Gal/GalNAc lectin has demonstrated the ability to bind to other substrates of the host 
which include; erythrocytes, neutrophils and colonic mucin glycoproteins. After adhesion, 
the trophozoites colonize the large intestine (Petri Jr et al., 2002). 
 
 E. histolytica kills targeted host cells by adhering to them, inducing their death and then 
ingesting them. Lectin mediated adherence is initiated by the parasite, thereafter the 
intracellular calcium is increased and host proteins are dephosphorylated. The parasite 
completes the kill process by tricking the host cell to induce apoptosis, resulting in host cell 
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death (Ralston and Petri Jr, 2011). Figure 2 illustrates the cytotoxic effect of E. histolytica 
on the host. 
 
 
Figure 2: Schematic Diagram of Stepwise Killing and Ingestion of Host Cells by E. 
histolytica (Ralston and Petri Jr, 2011)                                                                               
In the first step, E. histolytica attaches to the host cell by establishing a Gal/GalNAc lectin 
bond on the outer surface of the cell. Step two demonstrates the biochemical processes that 
occur and lead to host cell induced apoptosis. In the last step E. histolytica ingests the host 
cell. 
 
Bacteria and food particles are also ingested by the trophozoite.  Reproduction occurs in 
the colon by a process known as binary fission, encystation then follows. The infections 
cysts are shed into the environment via the faeces (Stanley Jr., 2003). The life cycle of 
Entamoeba histolytica is shown in Figure 3.  
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Figure 3: The Life Cycle of E. histolytica (Chiodini et al., 2003)                                   
E.histolytica cysts are ingested from the environment. The cysts pass down to the small 
intestine where they excyst and divide to form trophozoites. Invasion occurs in the large 
intestine, however the trophozoites may also disseminate to areas such as the liver and brain. 
When the lumen of the bowel is dehydrated, encystation occurs. Infectious cysts are passed to 
the environment with the faeces. 
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2.4.1.5. Treatment 
Nitroimidazoles such as metronidazole, tinidazole and ornidazole are used in the treatment 
of diarrhoea caused by E. histolytica (Stanley Jr., 2003).  
 
2.4.1.6. Diagnostic Methods used in the Detection of E. histolytica 
Microscopic techniques used include, wet-preps, concentration methods, the trichrome 
stain and the iron-hematoxylin stain. Wet preparations, are performed on fresh stool 
usually within one hour of collection and has a sensitivity of <10%. Concentration methods 
are helpful in the demonstration of cysts in asymptomatic patients; however, staining 
methodologies are helpful in the recovery and identification of Entamoeba species (Fotedar 
et al., 2007). 
 
Culture media used include xenic and axenic systems, with xenic systems referring to 
growth in the presence of an undefined flora and axenic systems referring to growth 
without other metabolizing cells being present.  Xenic media that can be used include 
monophasic TYSGM-9, Robinson’s medium and diphasic Locke-egg, whilst axenic media 
used include; TYI-S-33 and YI-S (Fotedar et al., 2007). 
 
Serological tests are also used, however their usefulness is limited to areas in which E. 
histolytica infection is uncommon. In endemic areas the problem that arises is 
differentiating between antibodies from past and present infections. Another disadvantage 
is that preserved stool specimens contain preservatives that may denature the target 
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antigens. In addition, a thousand trophozoites need to be present per well for successful 
detection (Fotedar et al., 2007). 
 
DNA based diagnostic tests such as PCR, is limited to research laboratories and developed 
countries. Due to the lack of facilities to conduct DNA based tests as well as the cost 
incurred, less sensitive detection methods are used in developing countries. Reports 
suggest PCR of the 18S rDNA gene is a hundred times more sensitive than the best ELISA 
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2.4.2. Giardia lambliae 
2.4.2.1. History 
Giardia was initially described in 1681 after Leeuwenhoek reported on the examination of 
his own diarrheal stool (Dobell, 1920). The organism was described further by Lambl in 
1859. Lambl named it Cercomonas intestinalis, as he had thought it belonged to the genus 
Cercomonas based on the morphological resemblances (Lambl, 1859).  
 
There was much controversy emanating from naming this organism, since some scientists 
named the organism according to the observed morphology, whilst others named the 
organism based on the host in which it originated from. In 1888, Blanchard suggested the 
name Lambliae intestinalis, (Blanchard, 1888). 
 
 In 1902 Stiles, suggested the name to Giardia duodenalis (Stiles, 1902).  Shortly 
thereafter, Kofoid and Christiansen suggested the names G. lambliae in 1915 and in 1920, 
the name G. enterica (Kofoid and Christensen, 1915 and1920).  In the 1970s the name G. 
lambliae was widely accepted and used (Adam, 2001).  
 
2.4.2.2. Morphology 
G. lambliae trophozoites are pear shaped with a diameter of 5-9 micrometres and a length 
of 12-15 micrometres. The cytoskeleton is made up of a median body and a ventral disk. 
Two nuclei are present and are identical in appearance. In addition these nuclei replicate at 
the same time. Four pairs of flagella also constitute the morphology. The trophozoites also 
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have an axostyle which is composed of two axonemes that can be seen in Figure 4. During 
microscopic observations the axostyle, nuclei, parabasal (median) body and flagella may 
be visible. G. lambliae cysts measure 5 by 7-10 micrometres in diameter. The cysts are 
composed of an outer filamentous layer and a double inner membranous layer (Adam, 
2001).  
 
Figure 4: G. lambliae Morphology and Life Cycle (Chiodini et al., 2003)                      
G. lambliae cysts are ingested from the environment and pass to the small intestine, where 
they excyst to form trophozoites. After excystation the trophozoites undergo binary fission in 
the small intestine. In the jejunum the trophozoites encyst and are then shed into the 
environment with the faeces. 
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2.4.2.3. Transmission 
Infectious G. lambliae cysts are transmitted through faecal contaminated water and food or 
through person to person contact. G. lambliae has a low infectious dose, requiring only 10 
cysts to establish infection (Rendtorff, 1954). This cyst is resistant to chlorination and can 
survive for a week in cold water (deRegnier et al., 1989 and Johns et al., 1995).   
 
2.4.2.4. Symptoms and Signs  
One to three weeks after cysts are ingested, clinical symptoms such as diarrhoea, 
flatulence, malaise, abdominal cramps and the presence of greasy stools can be observed 
(Wolfe, 1979 and Hill, 1993). Patients may also display fever, bloody or mucoid stool, 
vomiting, bloating and anorexia (Moore et al., 1969). 
 
2.4.2.5. Life Cycle 
Two major stages occur in the life cycle of Giardia lambliae. Ingested cysts pass through 
the stomach, withstand the low pH and digestive enzyme activity and travel to the small 
intestine where they excyst into trophozoites. Trophozoites replicate in the small intestine 
whilst simultaneously causing diarrhoea and malabsorption. In the jejunum the 
trophozoites encyst and are excreted with the faeces. Upon release into the environment a 
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2.4.2.6. Detection Methods 
Various detection methods exist for identification of cysts and trophozoites. The 
concentration of giardia cysts vary in the stool over time which is a diagnostic challenge. 
Culture techniques are also used but these are limited to research centres. Serological 
techniques are generally used in epidemiological surveys (Gardener and Hill, 2001). The 
trichrome stain was reported by Idris and Al-Jabri (2001) to be superior to all other 
microscopic based identification techniques investigated. This is because it has the ability 
to detect both cysts and trophozoites of protozoa. Ultimately PCR-based methods have 
been shown to be more sensitive as well as specific when compared to microscopy and 
antigen detection tests (Verweij et al., 2004).  
 
2.4.2.7. Treatment 
G. lambliae is treated with nitroimidazoles such as, metronidazole, secnidazole, ornidazole 
and tinidazole.  However, the challenge with using nitroimidazoles is the inability of the 
drug to penetrate the cyst wall. Hence effective removal of the trophozoites is questionable. 
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2.4.3. Cryptosporidium parvum 
2.4.3.1. History 
In 1907, Ernest Edward Tyzzer first described Cryptosporidium species. However, it was 
only recognised as a pathogen in 1955, during an outbreak of diarrhoea among a flock of 
turkey. The first case of Cryptosporidium infection in humans was reported in 1976.  In 
later years, C. parvum was recognized as an important cause of diarrhoea with immune 
impaired symptoms as a result of the emergence of AIDS. It was only in 1987 that it was 
recognised as the cause of waterborne infections in immune-competent individuals (Rose, 
1988). 
 
2.4.3.2. Morphology  
 Of primary importance, is the oocyst stage, as dispersal, survival and infection occur 
during this phase. In addition it is also the stage in which detection as well as identification 
of the parasite is made (Fayer et al., 2000).  Identification of C. parvum is challenging as 
oocysts can easily be confused with yeast cells, algae and plant debris present in cells. 
Differentiation of species is challenged by the fact that most oocysts are 4-6 µm, nearly 
spherical and possess obscure internal structures (Fayer et al., 2000). 
 
The oocyst wall of C. parvum is made up of rich disulphide bonds (Mitschler et al., 1994), 
which is protective to the infectious sporozoites. The oocyst walls have two layers, an inner 
and an outer layer. The outer layer is composed of acidic glycoproteins (Reduker et al., 
1985), whilst the inner layer is filamentous and composed of glycoproteins.  The central 
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glycolipid / lipoprotein layer is believed to be responsible for the rigidity and elasticity of 
the wall (Bonnin et al., 1991).  
 
2.4.3.3. Life Cycle 
The life cycle of C. parvum includes a sexual and an asexual phase.  Once the infectious 
form is ingested, changes in the environmental conditions of the host such as temperature, 
pH, pancreatic enzymes and bile salts, result in excystation of four sporozoites from each 
oocyst (Reduker et al., 1985).  These sporozoites adhere to the luminal surfaces of 
epithelial cells of the infected tract. Microvilli of epithelial cells surrounding the sporozoite 
facilitate intracellular uptake of the sporozoites. After microgametes and merozoites leave 
the host cell, they go on to infect other cells. In the parasitophorous vacuole, the 
endogenous life cycle occurs (Tzipori and Widmer, 2000). Development of the parasite is 
facilitated by the protective effect exhibited by the membrane of the parasitophorus 
vacuole, against the host defence system. 
 
The presence of a feeder organelle between the cytoplasm of the host and the parasite, 
allows for energy and nutrient uptake from the host (Carey et al., 2004).  After two 
generations of successful merogony, Type 1 and Type 2 meronts that contain 6-8 and 4 
merozoites, respectively, are released. When a mature merozoite infects another host cell, 
the merozoite develops into a Type 1 or Type 2 meront, this is known as asexual 
multiplication.   
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Type 2 meronts differentiate into microgamonts and macrogamonts, the sexual component 
of the life cycle. Microgamonts become multinucleated, with each nucleus being 
incorporated into a microgamete. When the microgamete is fertilized, the macrogamont 
undergoes division twice to become an oocyst. Thin-walled as well as thick-walled oocysts 
develop during sporogony, with each oocyst containing four sporozoites that have the 
potential to cause infection.  
 
 Autoinfections as well as persistent infections are the result of thin-walled oocysts that 
remain within the host. Oocysts that possess a thick wall are shed into the environment via 
excretion of faeces. The life cycle of C. parvum is quite rapid occurring within twelve to 
fourteen hours of ingestion. Therefore few oocysts are required to cause infection (Current 
and Garcia et al., 1991). The life cycle of C. parvum is shown in Figure 5. 
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Figure 5: C. parvum Life Cycle (Chiodini et al., 2003)                                                            
C. parvum undergoes two phases; a sexual phase and an asexual phase. Once oocysts are 
ingested, they excyst to form sporozoites. With asexual replication a mature merozoite 
develops into a Type 1 or Type 2 meront. With sexual replication, a Type 2 meront divides to 
form a microgamont and macrogamont. Sporogony results in the formation of thick-walled 
oocysts and thin-walled oocysts. Thick-walled oocysts are excreted with the faeces and are 
released into the environment. 
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2.4.3.4. Survival and Transmission 
Oocyst survival is largely dependent on temperature, as oocysts have the ability to survive 
in temperatures between 4°C-22°C (Pokorny et al., 2002). Furthermore, cysts can survive 
in sea water as well as fresh water. Although an increase in temperature speeds up the 
process of oocyst degradation, oocysts are still known to be infective for twelve weeks at 
25 °C in water (Fayer et al., 1996).  
 
Transmission of oocysts via the faecal-oral route is mediated by numerous factors. These 
factors include person to person contact either through direct contact or indirect contact. 
Animals may also transmit oocysts to other animals or to humans. In cases of zoonotic 
transmission, infected humans such as farmers generally contract the infection due to their 
close contact with animals. Oocysts may be present in recreational water that is used for 
activities such as swimming and water that is used for consumption. When oocysts are 
transmitted through food, it is generally due to contamination emanating from lack of 
hygiene of food handlers. 
 
 Air borne transmission occurs through dispersal of oocysts present in soil by 
environmental conditions such as wind. Faecal contamination of the soil and surface water 
with C. parvum oocysts may lead to further contamination of fresh fruits and vegetables, 
drinking water and recreational water. Sexual activities have also been documented in the 
transmission of oocysts (DuPont et al., 1995). However, spread through the faecal-oral 
route with water as the main vehicle of transmission is a global concern and threatens 
drinking water safety worldwide (Carey et al., 2004). 
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Conventional methods to eradicate C. parvum from water supplies, such as coagulation, 
flocculation, sedimentation, filtration and chemical treatment, have proven to be 
unsuccessful (Carey et al., 2004). Chlorine is effective in killing bacteria but not oocysts. 
Hence coliform counts which are generally used as indicators for faecal contamination, do 
not provide evidence for the presence or absence of C. parvum (Chauret et al., 1995). No 
biological indicators exist to determine the presence of C. parvum (Carey et al., 2004). 
 
 Due to the small size of oocysts, they can pass through most conventional filters. Removal 
of oocysts is possible with one micrometer absolute filters and reverse-osmosis filters 
(Steiner et al., 1997). For effective removal of oocysts chemical and physical treatment 
should be incorporated (Carey et al., 2004). 
 
2.4.3.5. Detection 
Various detection methods exist for C. parvum. These include concentration and staining 
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Table 2.2.: Differential Staining Techniques for C. parvum 
Various staining techniques can be used to differentiate C. parvum from other organisms 
present. Oocysts either stain a different colour compared to the background or may possess a 
halo around the oocyst wall. 
 
Negative staining methods, stain bacteria, yeasts and the background, but not oocysts. This 
requires examination by an experienced microscopist (Fayer et al., 2000). The Ziehl-
Nelsen, Kinyoun and carbol fuchsin stains either stain the background green or blue since 
it depends on which counter stain is available for use. Generally it is either malachite green 
or methylene blue.  
 
PCR is also used as an alternative to conventional diagnosis. Immunological-based 
detection methods such as, ELISAs, immunofluorescence, reverse passive 
haemagglutination and immunochromatographic assays, among others may also be used 
(Fayer et al., 2000). Within the Cryptosporidium genus, antigens of the oocyst wall are 
conserved hence monoclonal antibody testing is not advised, as it does not differentiate 
between the different species of Cryptosporidium (Fayer et al., 2000). 
 
 
Staining technique Colour oft the visible oocysts Colour of background stain
Ziehl-Neelsen stain Red Blue or green
Kinyoun stain Pale or bright pink Dark green or blue
Safarin-methylene blue stain Orange to red Blue 
Auromine-phenol fluorochrome stain Yellow/green/orange Red
Carbol fuchsin stain Bright red Light blue
 DMSO- stain Red Green
Nigrosin stain Unstained halos Pink
Malachite green negative stain Unstained halos Green
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2.4.3.6. Treatment 
C. parvum can be treated with nitazoxanide, which is a derivative of nitrothiazolyl-
salicylamide (Rossignol and Stachulski, 1999). This has been demonstrated in both cell 
culture and animal models (Theodos et al., 1998, Blagburn et al., 1998 and Gargala et al., 
2000). A three day course of nitazoxanide is successful in treating intestinal protozoal 
infections (Abaza et al., 1998, Romero et al., 1997 and Vásquez et al., 1998). Nitazoxanide 
is effective against C. parvum in AIDS patients.  However, the efficacy varies based on the 
duration of treatment and the degree of immunosuppression (Davis et al., 1996 and 
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Chapter Three: Materials and Method 
3.1. Study Design 
This study is a cross-sectional study, which aimed to determine the prevalence of protozoal 
parasites causing diarrhoea in children aged 0-5 years in the eThekwini district of 
KwaZulu-Natal. 
 
The study population consisted of children in that age group, who attended the King 
Edward VIII hospital’s outpatient clinic or were admitted to the gastroenteritis ward.  
Children, producing loose stools frequently were enrolled in the study. King Edward VIII 
Hospital was chosen as the study location, since it is within close proximity of the 
university’s medical microbiology laboratories.  
 
The sample size was calculated by taking an estimated prevalence of 29%, p = 0.29 
(Mukhopadhyay et al., 2007, Adamu et al., 2006, Tigabu et al.,2010, and Nxasana et 
al.,2014).  A precision of + /- 8% with a confidence of 95% was accepted, which resulted 
in a minimum sample size of 124 participants 
 
3.2. Ethical Considerations 
Ethical approval to conduct this study was obtained from the University of KwaZulu-
Natal’s   Biomedical Research Ethics Committee (BREC). The ethics number for this study 
was BE222/13.    
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3.3. Specimen Collection  
Prior to the collection of stool, the research nurse and I had given the caregivers a detailed 
explanation of the purpose of the study and the process of informed consent.  
Questionnaires were also conducted and caregivers were encouraged to co-operate, as part 
of the enrolment process. Stool specimens from 249 children were collected in sterile leak-
free universal containers. These containers were labelled with the participants’ study 
numbers. Stool specimens arrived at the laboratory on the same day of collection. On 
arrival at the laboratory, part of the specimen was stored at -20°C for molecular analysis 
and the remaining stool was preserved in phosphate buffered formalin (5% v/v). The 




3.4. Microscopic Analysis 
Detection of protozoal cysts in stool was done by means of light microscopy.  Preserved 
specimens were smeared onto glass microscope slides. The smears were allowed to dry 
which was followed by a staining technique suitable for the protozoan we were attempting 
to detect.  
 
Two staining techniques were applied: the modified trichrome stain which allows detection 
of most species of protozoa and the modified Ziehl-Neelsen stain which is a differential 
staining technique for the acid fast oocysts of Cryptosporidium parvum. 
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3.4.1. The modified Trichrome Stain According to the Ryan-Blue Protocol 
The modified trichrome stain was performed according to the Ryan-Blue protocol. The 
components to make up the staining solution are shown in Table 3.1. The solution was 
prepared by adding 3 ml of acetic acid to the dry ingredients. The container with the 
solution was covered with aluminium foil, incubated for 30 minutes at room temperature in 
the dark. Following this, 400 ml of distilled water was added and the pH was adjusted by 
adding drops of 1.0 M HCl till the required pH of 2.5 was reached. 
 
Table 3.1.: Formula for the Modified Trichrome staining solution 
                                       
 
 The stored specimen was mixed till an even suspension was obtained. Using a Pasteur 
pipet, a drop was placed onto a microscopy slide. This was air-dried at 37°C. Thereafter 
slides were placed in the trichrome stain for 90 minutes. This was followed by rinsing with 
3 % acid alcohol. To remove the acid, slides were dipped seven times in 95% ethanol. This 
was followed by placing the slide in 100% ethanol for 3 minutes. This last step was 
repeated before exposure to accustain exylene for 10 minutes. Slides were then air dried at 
room temperature and a cover slip was mounted on top of the specimen using DPX (Ryan 
et al., 1993).   
 
Chemical Components Quantity Concentration
Chromotrope 2R 24 g 0.13M
Aniline blue 2 g 0.006M
Phosphotungstic acid 1 g 0.9M
Acetic acid (glacial) 12 ml 0.5M
Distilled water 400 ml
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3.4.2. The Modified Ziehl-Neelsen Staining Technique 
For the modified Ziehl-Neelsen technique, a drop of the faecal specimen was placed onto a 
microscopy slide and air dried at 37°C. The material was stained with carbol fuchsin for 20 
minutes, rinsed under the tap and decolourised with 3% acid alcohol for 20 seconds. The 
slide was rinsed under the tap and counter stained with methylene blue for 60 seconds. A 
final rinse was performed under the tap and the slides were left to air dry.  Once dry, a 
cover slip was mounted on top of a smear using DPX (Adamu et al., 2006).   
 
3.4.3. Microscopy 
An Olympus BX4OF-3 model bright field microscope was used to screen specimens at 400 
x magnification. Suspected objects were then viewed at 1000 x magnification.  The entire 
area (22mm x 7mm) under the cover slip was screened. Images of the cysts and oocysts 
were captured using the Image Pro-Plus camera software on the Leica DM 3000 
microscope.   
 
3.4.4. The Formol-Ether Concentration Technique 
A pea-size portion of stool was added to an unused stool container and emulsified in 10 ml 
of 4% formaldehyde in saline. The suspension was then filtered through gauze into a clean 
20 ml conical collection tube and 3 ml of ether was added to the filtrate. The tube was 
closed and shaken vigorously for 30 seconds.  
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Thereafter the suspension was filtered once again through gauze into a clean 20 ml conical 
collection tube. After centrifugation four layers had formed viz. the ether layer, the plug of 
debris, the layer containing the 10% formal saline and the last layer containing the deposit 
of intestinal parasites. The ether, plug of debris and formal saline layers were decanted into 
a waste bucket and the deposit was kept in the fridge at 4°C. 
 
3.5. DNA Extraction Techniques 
Different DNA extraction methodologies were explored to obtain DNA from C. parvum 
oocysts and G. lamblia cysts. Four clinical specimens that tested positive on microscopic 
examination were used to test DNA extraction methods. In addition, four positive 
specimens (C. parvum 1, C. parvum 2, G. lamblia 1 and G. lamblia 2) obtained from a 
private laboratory were also used. These were specimens that were not preserved in 
formalin. To confirm the presence of C.parvum, Ziehl-Neelsen stained smears were 
prepared and viewed. Similarly, iodine stained wet-preps were made with G. lambliae 
positive specimens. The different DNA extraction methods tested are listed in Table 3.2.  
 
DNA was quantified and qualitatively assessed with the Thermo Scientific Nanodrop 
2000c spectrophotometer. DNA was considered “good” if the quantity was >10 ng/µl. The 
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Table 3.2.: DNA Extraction Techniques 
                  
 
 
3.5.1. QIAamp Fast DNA Stool Mini Kit Protocol (A) 
The kit manufacturer’s instructions were followed. All reagents and buffers were provided 
with the kit. 
A pea-size amount of stool was added to a clean 2 ml microcentrifuge tube and 1 ml of 
inhibitEx was added, followed by vortex agitation for 1 minute. The suspension was heated 
at 95°C for 5 minutes to allow lysis of the cysts. After vortexing for 15 seconds, the 
specimens were centrifuged for 1 minute to remove solid stool particles. Fifteen µl of 
proteinase K was mixed with 200 µl of supernatant from the previous step and 200 µl of 
buffer AL. This mixture was vortexed for 15 seconds and incubated for 10 minutes at 
70°C. 
 
After incubation, 200 µl of absolute ethanol was added, followed by vortex agitation for 15 
seconds. A QIAamp spin column was then placed in a 2 ml collection tube, 600 µl of lysate 
from the previous step was added to the spin column and this mixture was centrifuged for 1 
minute at 14000 x g. After centrifugation, the filtrate from the spin column was discarded 
and the spin column was transferred to a new 2 ml collection tube.  The next step entailed 
adding 500 µl of wash buffer AW1 to the spin column and centrifugation for 1 minute.   
DNA Extraction Techniques
A. The QIAamp Fast DNA Stool Mini Kit Qiagen Hilden, Germany
B. CTAB Method Van Embden et al ., 1993
C. QIAamp DNA Mini Kit (protocol for blood specimens) Qiagen Hilden, Germany
D. QIA amp DNA Stool Mini Kit (protocol for stool specimens) Qiagen Hilden, Germany
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The filtrate from the spin column was discarded and the spin column was placed in a new 2 
ml collection tube, followed by the addition of 500 µl of wash buffer AW2 and 
centrifugation for 3 minutes at 14000 x g. After centrifugation the filtrate from the spin 
column was discarded and the spin column was placed in a new 2ml collection tube and 
centrifuged for 3 minutes.  
 
The QIAamp spin column was then placed in 1.5 ml microcentrifuge tube and 200 µl of 
ATE buffer was added directly onto the membrane of the spin column. A minute of 
incubation at room temperature and a subsequent centrifugation for 1 minute to elute the 
DNA then followed. 
 
No measurable amount of DNA was obtained applying this method. Hence a number of 
different modifications were tried: 
1. DNA was eluted in 60 µl of ATE buffer instead of 200 µl of ATE buffer 
 
2. The lysis temperature was increased to 100°C for 10 minutes instead of  95°C for 5 




3. An additional step was incorporated prior to performing DNA extraction. This step 
included adding 180 µl of ATL buffer and 20 µl of proteinase K to the stool 
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specimens and placing this in a 56°C water bath for 3 hours. The addition of 
proteinase K in other steps was omitted. 
 
4.  Modification number 1 was modified by adding silica beads to a 2ml 
microcentrifuge tube containing a pea-size portion of the stool. The stool specimen 
was subjected to three cycles of vortex agitation for 60 seconds and placing on ice 
for 2 minutes. Centrifugation for 10 minutes at 12000 x g then followed. 
 
3.5.2. Cetyl Trimethyl Ammonium Bromide (CTAB) Method for DNA Extraction (B) 
Seventy µl of 10% (w/v) sodium-dodecyl sulphate (SDS) and 50 µl of proteinase K were 
added to 200 µl of stool. The tubes were placed in a 60°C water bath for 60 minutes 
followed by the addition of 100 µl of 5M NaCl .The tubes were inverted seven times to 
mix the suspension. Thereafter 100 µl of warm CTAB was added. The contents of the 
tubes was mixed by hand inversion and incubated at 60°C for 15 minutes followed by 
freezing by placing the tubes at -70°C for 15 minutes. This was followed by thawing in a 
60°C water bath and 700 µl of chloroform/isoamyl alcohol (24:1) was added and mixed by 
inversion. The mixture was then centrifuged for 10 minutes at 13000 x g.  The upper 
aqueous layer that formed was then transferred to a new tube. Thereafter, 700 µl of cold 
isopropanol was added and the tube was inverted seven times. 
 
 The extracts were then kept at 4°C overnight followed by centrifugation for 10 minutes at 
13000 x g. The fluid was removed and the deposit suspended in 70% (v/v) ethanol. This 
suspension was centrifuged for 10 minutes at 13000 x g. Ethanol was removed and the 
remaining DNA was left to air-dry.  Based on the size of the resulting pellet, 10-30 µl of 1x 
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(v/v) TE buffer was used to re-suspend the DNA. The DNA was stored at -20°C till further 
use. 
 
The DNA obtained with the CTAB method varied in quantity and quality. When the PCRs 
(3.6) were tried on the good extracts; no amplicons was found. Therefore the formol-ether 
concentration technique was applied and the CTAB DNA extraction method repeated. This 
did not improve the results.  
 
3.5.3. QIAamp DNA Mini Kit Protocol for Blood Specimens (C) 
The kit manufacturer’s instructions were followed. All reagents and buffers were provided 
with the kit. 
A pea-size portion of stool was placed in a 2 ml microcentrifuge tube, 200 µl of TE buffer 
was added and the suspension was boiled for 15 minutes at a 100°C. The suspension was 
kept at 4°C overnight and centrifuged for 5 seconds at 8000 x g.  The supernatant was 
aspirated and decanted into a 2 ml microcentrifuge tube. Thereafter, 200 µl of buffer AL 
and 20 µl of proteinase K were added to the supernatant, followed by vortex agitation for 
15 seconds and centrifugation at 8000 x g for 5 seconds. This mixture was then placed in a 
56°C water bath for 10 minutes and 200 µl of 70% (v/v) ethanol was added. Vortex 
agitation for 15 seconds and centrifugation at 8000 x g for 5 seconds, followed.  
 
The lysate from the previous step was added to a spin column and centrifuged for 1 minute 
at 8000 x g. The spin column was placed in a new 2 ml collection tube and the filtrate and 
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the collection tube was discarded.  Thereafter 500 µl of wash buffer AW1 was added to the 
spin column and the tube was centrifuged for 1 minute at 8000 x g. The filtrate was 
discarded, the spin column was placed in a new 2 ml collection tube and 500 µl of wash 
buffer AW2 was added. Centrifugation for 3 minutes at 14000 x g followed. 
 
The spin column was transferred to a new 2 ml collection tube, the filtrate was discarded 
and the tubes were centrifuged for 1 minute at 14000 x g. The spin column was placed in a 
1.5 ml microcentrifuge tube, the filtrate and collection tube was discarded and 60 µl of 
elution buffer AE was added to the spin columns. Incubation for 5 minutes at room 
temperature followed, as well as a subsequent centrifugation at 8000 x g. Thereafter the 
spin column was discarded and DNA was kept at -20°C. 
 
3.5.4. QIAamp DNA Mini Kit Protocol for Tissue Specimens (D) 
The kit manufacturer’s instructions were followed. All reagents and buffers were provided 
with the kit. 
A pea-size portion of stool was added to a 2 ml microcentrifuge tube. To this 180 µl of 
ATL buffer and 20 µl of proteinase K was added. The tubes were vortex agitated for 15 
seconds and centrifuged for 5 seconds at 8000 x g. Incubation of this mixture for 3 hours in 
a 56°C water bath then followed. Two hundred µl of buffer AL was added and the mixture 
was incubated at 70°C for 10 minutes. Then, 200 µl of 70% (v/v) ethanol was added to the 
tubes, followed by vortex agitation for 15 seconds and centrifugation at 8000 x g for 5 
seconds. 
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The lysate was added to a spin column and centrifuged for 1 minute at 8000 x g. The spin 
column was placed in a new 2 ml collection tube and the filtrate was discarded. Five 
hundred µl of wash buffer AW1 was added to the spin columns and centrifuged for 1 
minute at 8000 x g. The spin column was transferred to a new 2 ml collection tube; the 
filtrate was discarded and 500 µl of wash buffer AW2 was added to the spin column. 
 
Centrifugation for 3 minutes at 14000 x g followed. The spin column was then placed in a 
new 2 ml collection tube, the filtrate was discarded and the tubes were centrifuged for 1 
minute at 14 000 x g. The spin column was transferred to a 1.5 ml microcentrifuge tube, 
the filtrate and collection tube was discarded and 60 µl of elution buffer AE was added to 
the spin columns.   Incubation for 5 minutes at room temperature and centrifugation at 
8000 x g for 1 minute followed. The spin column was discarded and the DNA was kept at -
20°C. 
 
To improve the results this DNA extraction technique was repeated following two different 
procedures applied before the extraction took place: 
1. Formol-ether concentration technique of the stool specimens. 
 
2. Vortex agitation (3 x 60 seconds) followed each time by cooling on ice for 2 
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3.6.  Polymerase Chain Reaction (PCR)  
3.6.1. Initial PCR Protocol 
Polymerase Chain Reaction as described by the protocol from the AmpliTaq® Gold DNA 
Polymerase kit was performed using  DNA extracted by the different methods as described 
in 3.5 from specimens that were confirmed positive for Cryptosporidium parvum and 
Giardia lambliae. The concentration and quality of the DNA was determined using a 
spectrophotometer (Nanodrop), the purity was further confirmed by means of gel 
electrophoresis. 
  
PCRs were performed according to the AmpliTaq® Gold DNA Polymerase kit’s 
recommendations (AmpliTaq® Gold DNA Polymerase Protocol, Pub. No. MAN0009863 
Rev. A.0., 2014, ThermoFisher Scientific) for both Cryptosporidium parvum and Giardia 
lambliae. Both PCRs was performed using a 25 µl reaction volume. PCR master mix 
components are listed in Table 3.3. The amount of template DNA used can be seen in 
Table 3.4. Apart from the primers (Table 3.5.), the components were the same. Following 
the kit’s recommendations, no amplification of the expected products was achieved. Hence 
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Table 3.3.: Mastermix Components  
                                                      
These components constituted the 25 µl mastermix reaction for C. parvum and G. lambliae 
 
Table 3.4. The amount of template DNA used for test specimens 
                                                                
DNA extraction protocols yielded sufficient DNA with good purity for 5 specimens: 4 with the 
tissue protocol (D) and 1 with the CTAB method.  PL3 represents a positive C. parvum 
specimen from a private laboratory, and PL4 represents a positive G. lambliae specimen from 
a private laboratory. 
 




10 x PCR  buffer II 2.5
10mM dNTP mix 0.5
25mM MgCl2 1.5
10µM Forward primer 0.5
10 µM Reverse primer 0.5
Amplitaq gold DNA polymerase (5U/µl)0.125 (0,625 U)
Nuclease-free water 11.375
Template DNA Quantity (ng/8µl)
Specimen 3 (Protocol C) 165.6
Specimen 3 (Protocol D) 556,8
Specimen 183 (Protocol D) 92,8
Specimen 191 (Protocol D) 552
Specimen 294 (Protocol D) 85.6
PL3 (Protocol D) 127.2
PL4 (Protocol D) 136
PL3 (Protocol D: Silica beads) 49.6
Parasite Primer name Primer Sequence Reference
AWA722F (Forward) 5’AGTGCTTAAAGCAGGCAACTG 3’
AWA1235R (Reverse) 5’ CGTTAACGGAATTAACCAGAC 3’
RH 11 (Forward) 5’ CATCCGGTCGATCCTGCC 3’
RH4 (Reverse) 5’AGTCGAACCCTGATTCTCCGCCAGG 3’
C. parvum
G. lambliae
Elsafi et al.,  2013
Hopkins et al.,  1997
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PCRs were performed using the ABI 9700 thermo cycler. Except the annealing 
temperature, the cycling conditions were the same for both the C. parvum and the G. 
lambliae. The cycling conditions are shown in table 3.6.  PCR followed a protocol that 
recommended an initial denaturation at 95°C for10 minutes to activate the enzyme. A final 
extension of 72°C for 5 min was performed. The expected product size for C. parvum and 
G. lambliae was 556 bp and 292 bp, respectively. 
 
Table 3.6.: PCR Cycling Conditions for C. parvum and G. lambliae 
                   
The same conditions were used for both parasites. Only the annealing temperature differed. 
G. lambliae displayed a higher annealing temperature than C. parvum. 
 
3.6.2. Optimisation of PCRs 
The following modifications to the above protocol were tried: 
 
1. 5 µl of DNA was used instead of 8 µl (Table 3.8.). The decreased volume was 
replaced with additional µl of nuclease-free water.  
 
2. The master mix composition was adjusted as shown in Table 3.7.  
 
Conditions
Denaturation 95°C for 15 seconds
Annealing 52°C (C. parvum ) and 59°C (G. lambliae ) for 30 seconds 
Extension 72°C for 1 minute/kb 
No. of cycles 35
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Table 3.7.: The Mastermix Components and DNA Template 
          
This table represents the modifications made to the AmpliTaq® Gold DNA Polymerase 
Protocol’s mastermix. 
 
Table 3.8. The Initial and Adjusted Amounts of Template DNA Used 
                     
This table shows the reduced amounts of template DNA used 
 
 
3. The following protocol was tried using the adjusted master mix and template DNA 
(Table 3.7. and 3.8.): 
 
- Initial denaturation at 95°C for 5 minutes 
- Denaturation at 95°C for 1 minute (35 cycles) 
Amplitaq's Protocol Adjustment
10 x PCR  buffer II 2.5 2.5
10mM dNTP mix 0.5 0.75
25mM MgCl2 1.5 0.9
10µM Forward primer 0.5 1
10 µM Reverse primer 0.5 1
Amplitaq gold DNA polymerase (5U/µl) 0.125 (0.625 U) 0.2 (1 U)
Nuclease-free water 11.375 13.6 5
Template DNA 8 5
Component
Quantity (µl)
    Initial DNA (8µl)                                                Adjustment (5 µl)
Specimen 3 (Protocol C) 165.6 103.5
Specimen 3 (Protocol D) 556,8 348
Specimen 183 (Protocol D) 92,8 58
Specimen 191 (Protocol D) 552 345
Specimen 294 (Protocol D) 85.6 53.5
PL3 (Protocol D) 127.2 79.5
PL4 (Protocol D) 136 85
PL3 (Protocol D: Silica beads) 49.6 31
Template DNA
Quantity (ng/µl)
  Page | 46  
 
- Annealing at 52°C for 30 seconds 
- Extension at 72°C for 1minute 
- Final extension of 72°C for 5 minutes 
 
4. The conditions as advised for the Qiagen Fast cycling PCR kit were applied for the 
C. parvum PCR using the adjusted master mix (Table 3.7.) and template DNA 
(Table 3.8.): 
 
- Initial denaturation at 95°C for 5 minutes 
- Denaturation at 96°C for 5 seconds (35 cycles) 
- Annealing at 52°C for 5 seconds 
- Extension at 68°C for 17 seconds 
- Final extension of 72°C for 1 minute 
 
 
5. The following conditions for G .lambliae detection were tried (Hopkins et al., 
1997) using the adjusted master mix: 
 
- Initial denaturation at 96°C for 2 minutes 
- Denaturation at 96°C for 20 seconds (35 cycles) 
- Annealing at 59°C for 20 seconds 
- Extension at 72°C for 30 seconds 
- Final extension of 72°C for 7 minutes 
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6. The annealing temperatures used by Elsafi (2013) and Hopkins (1997) for C. 
parvum and G. lambliae respectively (Table 3.6.), were varied by increments of 
1°C above and below the melting temperature (Tm) to a maximum of + 5°C. These 
temperatures were applied using the adjusted master mix (Table 3.7. and Table 3.8.) 
and conditions as per Table 3.6. 
 
 
7. The melting temperature (www.thermofisher.com) was calculated based on the 
primer sequences shown in Table 3.5 and verified on the Neb Tm calculator. The 
calculated Tm was 46.4°C for C. parvum and 54.3°C for G. lambliae.  
 
3.7. Statistical Analysis 
Age in months is the only numeric data.  Its frequency distribution did not meet the criteria 
for normality using Shapiro Wilks test.  Therefore the median and interquartile ranges were 
used as summary statistics and the non-parametric two-sample Wilcoxon rank-sum (Mann-
Whitney) test were used to compare positive and negative patients.  Chi square tests or 
Fisher’s exact test (depending on the number of observations in each category) were used 
to compare categorical data such as demographic characteristics of positive and negative 
patients.  A p value of 0.05 was considered statistically significant.  Data was analysed 
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Chapter Four: Results 
4.1. Microscopy Results 
Table 4.1.1 shows the entero-pathogenic protozoa detected by each staining technique. 
Two parasites were detected G. lambliae (Fig 4.1.1.) and C. parvum (Fig 4.1.2.).                  
E. histolytica was not detected in both staining techniques used. The total number of 
patients harbouring a parasite is based on observations with both staining techniques. The 
term NPS refers to “no parasites seen”. There were more C. parvum than G. lambliae and 
this difference was significant (p < 0.001). G. lambliae stained blue with the Ziehl-Neelsen 
staining technique (Fig 4.1.3.). Two patients were co-infected with both parasites. 
Microscopic observations were confirmed by an experienced and independent laboratory 
technician. 
 
Table 4.1.1.: The Prevalence of Intestinal Parasites Stratified by Staining Technique 
in Children ≤ 5 years (n=251) 
 
                  No. (%)                     
 
Technique G. lambliae    C. parvum NPS 
Ziehl-Neelsen stain 2 (1) 38 (15.2) 212 (84.5) 
Trichrome stain   6 (2.4)    18 (7.2) 227 (90.4) 
Total no. of patients  8 (3.2) 52 (20.7)  191 (76) 
 
NPS: Number of parasites seen. Children that tested positive on both stains were counted 
once to account for the number of total patients infected. 
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Fig 4.1.1: G. lambliae trophozoite x 1000 (modified trichrome stain)                          
G. lambliae trophozoites stain pink against a light blue background.  
 
 
Fig 4.1.2: C. parvum oocysts x 1000 (modified Ziehl-Neelsen stain)                                           
C. parvum oocysts stain dark red against a blue background. The cysts displayed a typical 
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Fig 4.1.3: G. lambliae cyst x 1000 (modified Ziehl-Neelsen stain)                                     
Blue stained G. lambliae cysts are seen in the background. 
 
The age distribution of the participants is given in table 4.1.2. G. lambliae was only found 
in children < 23 months. C. parvum was detected in 42 of the 214 children in that age 
category. Therefore, the prevalence of both pathogens was, with 88% for G. lambliae and 
81% for C. parvum highest in children < 23 months. The median age for G. lambliae 
positive children was 10 months with an inter-quartile range of 3-18 months. The median 






G. lambliae cyst 
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Table 4.1.2.: G. lambliae versus C. parvum Prevalence Stratified by Age in Children ≤ 
5 years (n=251) 
 
                 No. (%)  
 Age G. lambliae  C. parvum  Total 
< 6 months 2 (25) 17 (33) 76 
6-11 months 2 (25) 11 (21) 65 
12-18 months 2 (25) 11 (21) 58 
19-23 months   1 (12.5) 3 (6) 15 
> 24 months 0  7 (13) 29 
Unknown   1 (12.5) 3 (6) 8 
Total    8 (100%)     52 (100%) 251 
 
The childrens ages were taken from their case charts. Those charts that had missing ages 
were refered to as “unknown”. 
 
 
Children belonging to the female gender haboured more protozoal parasites than males, 
(Table 4.1.3). C. parvum was present in 50% of females and 44% of males whilst, G. 
lambliae was present in 50% of female and 40% of male children. The gender was 
unknown in 3  C. parvum positive children and a single G. lambliae positive child. These 
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Table 4.1.3.: G. lambliae versus C. parvum prevalence stratified by gender in children 
≤ 5 years (n=251) 
 
                  
No. (%)    
 Gender G. lambliae  C. parvum  Total  
Male   3 (37.5) 23 (44) 134 
Female 4 (50) 26 (50) 107 
Unknown   1 (12.5) 3 (6) 10 
Total   8 (100)  52 (100) 251 
 
 
Table 4.1.4. shows that there was no correlation between an exposed or positive HIV status 
and children that were positive for G. lambliae. The status for 2 individuals that tested 
positive for G. lambliae  was unknown. However, of the children infected with C. parvum 
25% had a history of exposure to HIV and 10% tested positive. Of those that were infected 
with C. parvum 59% were HIV sero-negative and had no history of exposure. 
 
Table 4.1.4.: G. lambliae and C. parvum prevalence stratified by HIV status in 
children ≤ 5 years (n=251) 
 
  No. (%)  
 HIV Status G. lambliae  C. parvum  Total  
Exposed 0 13 (25) 36 
Positive 0 5 (10) 27 
Negative 6 (75) 31 (59) 171 
Unknown 2 (25) 3 (6)   17 
Total  8 (100) 52 (100) 251 
 
There was no known association between G. lambliae and HIV. However, an association 
between HIV and C. parvum was observed. 
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The drinking water source in the households to which the children enrolled in this study 
belonged, is shown in table 4.1.5. Only one child that was positive for C. parvum used 
water from a water tank, 36% had piped water in their dwelling and 17% used water from a 
communal tap at the site where they lived. None of the children that had C. parvum 
infection used the river as a water source and in 3 out of 52 Cryptosporidium positive 
children, the water source was unknown. Of the children infected with G. lambliae, 25% 
had piped water in their dwelling and 50% had access to water from a communal tap. One 
child sourced their water from the river; and  the water source used by the household of 
one other child could not be established. The differences seen in the water source for each 
parasite were not statistically significant (p >0.05). 
 
Table 4.1.5.: G. lambliae and C. parvum Prevalence Stratified by Water Source in 
children ≤ 5 years (n=251) 
 
                 No. (%)  
 Water Source G. lambliae  C. parvum  Total  
Piped in dwelling  2 (25) 19 (36) 75 
Piped on site  4 (50) 29 (56) 166 
River     1 (12.5) 0 2 
Water tank 0 1(2) 1 
Unknown    1 (12.5)      3 (6) 7 
Total   8 (100) 52 (100) 251 
 
The water source used was mostly piped water; however children still acquired parasitic 
infections. 
 
Table 4.1.6 summarises the type of sanitation used by children infected with entero-
pathogenic protozoa. The pit toilet system was used by 19% and flush toilets were used by 
73% of C. parvum positive children. Only one child that harboured C. parvum used the 
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ventilated improved pit (VIP) latrines toilet system and the sanitation status for 3 children 
was not known. For G. lambliae positive children, 25% used pit toilets and 50% used flush 
toilets. For one child sanitation status was unknown, the VIP toilet system was used by 
another child harbouring G. lambliae. 
 
4.1.6.: Prevalence of G. lambliae and C. parvum and toilet system used by households 
with children ≤ 5 years (n=251) 
 
                 No. (%) 
 Toilet System G. lambliae  C. parvum  Total  
Flush  4 (50) 38 (73) 195 
Pit latrines  2 (25) 10 (19) 39 
VIP*    1 (12.5)     1 (12.5) 9 
Unknown   1 (12.5) 3 (6) 8 
Total  8 (100) 52 (100) 251 
 
The majority of children harbouring either C. parvum or G. lambliae used a flush toilet 
system.* Ventilated improved pit (VIP) toilets are pit toilets that have been fitted with a vent 
pipe and fly screen. This is to reduce odour and flies from the toilet. 
 
The duration of diarrhoea prior to enrolment in the study is shown in table 4.1.7. Of the 
children positive for C. parvum, 58% had diarrhoea lasting between 1and 3 days, 21% 
between 4 and 7 days while the remaining 6% had diarrhoea for more than 7 days. The 
duration of diarrhoea was unknown in 15%.  Of the caregivers of the 8 children infected 
with G. lambliae 3 (38%) reported the diarrhoea to be present for 1 to 3 days and 2 (25%) 
for more than 7 days.  
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4.1.7.: The Duration of Diarrhoea and Prevalence of G. lambliae and C. parvum in 
Children ≤ 5 years (n=251)     
 
No. (%)  
 No. of days G. lambliae  C. parvum  Total  
1-3 days   3 (37.5) 30 (58) 120 
4-7 days   1 (12.5) 11 (21) 95 
> 7 days 2 (25) 3 (6) 16 
Unknown 2 (25)  8 (15) 20 
Total   8 (100) 52 (100) 251 
 
 
The nutritional status in children carrying an entero-pathogenic protozoon is illustrated in 
table 4.1.8. Of the children that were infected with C. parvum 28 (54%) were malnourished 
and 4 (14%) showed signs of kwashiorkor. Malnourishment without kwashiorkor was 
observed in 38% of children infected with G. lambliae. 
 
4.1.8.: Nutritional Status in Children ≤ 5 years (n=251) infected with G. lambliae and/ 
or C. parvum    
 
 No. (%) 
 Nutritional Status G. lambliae  C. parvum  Total  
Normal 4 (50) 21 (40) 110 
Malnutrition  3 (37.5) 28 (54) 118 
with kwashiorkor 0 4 (14) 15 
Unknown  1 (12.5) 3 (6) 8 
Total  8 (100) 52 (100) 251 
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4.2. DNA extraction results 
 
Before applying DNA extraction and PCR to all clinical specimens, the methodology was 
tested using microscopically positive specimens. The QIAamp Fast DNA Stool mini kit 
protocol (protocol A) did not provide DNA of sufficient quantity and quality (Table 4.2.1.).  
When the elution volume was decreased using the same QIAamp Fast DNA Stool mini kit 
protocol, the DNA concentration increased significantly, but the purity decreased.   
 
Table 4.2.1.: DNA Concentration and Purity using the QIAamp Fast DNA Stool Mini 
kit 
 
QIAamp Fast DNA Stool mini kit 
Study 
no. 
200 µl elution volume 60 µl elution volume 
DNA (ng/µl) Purity (260/280) DNA (ng/µl) Purity (260/280) 
3 0.4 0.35 4 5.2 
183 0.8 1.49 6.9 3.04 
191 0.1 0.11 13.4 2.97 
294 0.5 0.65 1.2 1.1 
The elution volume was reduced to obtain a higher concentration of DNA. 
 
With the CTAB extraction method (protocol B, Table 4.2.2), except for specimen number 
3, the nucleic acid concentration obtained was good, but the purity was not. An 
electrophoresis gel was done to establish DNA integrity (Fig 4.2.1). Specimen number 191 
produced a distinct band, whereas specimen 183 and 294 produced faint bands. Applying 
the CTAB protocol on formol-ether concentrated stool improved the results for specimen 
number 3 but not for the others. The PCR with the DNA from specimen number 3 was 
unsuccessful for both G. lambliae and C. parvum. 
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Table 4.2.2.: DNA Concentration and Purity using the CTAB Method 
 
                 
The CTAB method was evaluated using both concentrated and non-concentrated stools. The 
assumption made was that concentrating stool prior to the CTAB extraction will increase the 




Fig 4.2.1: DNA Extraction a result using the CTAB DNA Method                               
The molecular weight marker (MWM) is shown on the first lane, on the sixth lane one 
distinct DNA band can be seen, as well as a faint DNA band in lane 8. NC refers to the 
negative control 
 
When the QIAamp DNA mini kit protocol for blood specimens (protocol C. Table 4.2.3) 
was used, good DNA was obtained from only one of the four specimens. Ultimately, use of 
DNA (ng/µl) Purity (260/280) DNA (ng/µl) Purity (260/280)
3 0 0 20.7 1.78
183 18.1 1.4 0.9 0.95
191 70.9 1.67 4.6 1.6
294 16.1 1.05 11 1.65
CTAB Method
Non-concentrated stool Concentrated stool
Study no.










































  Page | 58  
 
the same QIAamp DNA mini kit with the protocol for tissue specimens (protocol D, table 
4.2.3) resulted in good quantities of DNA with sufficient purity. However, PCR on these 
specimens for both parasites produced primer dimers and no product (Fig 4.2.2.). 
 
Table 4.2.3.: DNA Concentration and Purity using the QIAamp DNA Mini Kit 
 
 
The protocols for blood and tissue specimens were used because of the different lysis steps, as 










DNA (ng/µl) Purity (260/280) DNA (ng/µl) Purity (260/280)
3 45.5 2.02 69.6 2.2
183 2.6 2.03 11.6 2.13
191 1.7 4.36 69 2.02
294 0 1.56 10.7 2.31
QIAamp DNA mini kit
Blood protocol Tissue protocol
Study no.
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Fig 4.2.2: Unsuccessful PCR using DNA extracted from the tissue protocol of the 
QIAamp DNA Mini kit 
The molecular weight marker (MWM) is shown on the first lane. The specimens used are 
represented by (S). NC refers to negative control.  The red block highlights the primer dimers 
that formed. The idea behind running this PCR was to get a positive C. parvum and G. 
lambliae DNA band, which would thereafter be sequenced. If the sequences were positive the 
DNA could be used as a control for all the specimens collected. 
 
DNA extraction methodologies were also tested on positive specimens from a private 
laboratory (Table 4.2.4.). Using a lysis temperature of 100°C for 10 minutes; resulted in 
DNA that was insufficient in amount and impure. Similar DNA was obtained when an 
additional step (addition of 180 µl ATL buffer and 20 µl of proteinase K to stool 
specimens, followed by incubation at 56°C for 3 hours) was  implemented before 
applying the QIAamp Fast DNA stool mini kit protocol (protocol A, Table 4.2.4). 
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 When silica beads were added to the specimens, prior to using protocol A, the DNA 
obtained remained impure as well as insufficient in quantity. When the QIAamp DNA 
mini kit protocol for blood specimens (protocol C, table 4.2.4.); was tried, the quantity 
and quality of DNA obtained was not sufficient for use with PCR. Acceptable quantity 
and quality of DNA was obtained from specimens PL3 and PL4 (protocol D, table 
4.2.4.) however, PCR was not successful. DNA extraction on formol-ether concentrated 
stool specimens by means of the protocol for tissue specimens (protocol D), rendered 
poor quality and quantity of DNA.  Silica bead pre-treatment on specimens before use of 
protocol D resulted in a low concentration but good purity for one specimen but no DNA 
for the other. PCR was unsuccessful on the specimen that had good purity. 
      
Table 4.2.4.: DNA Concentration and Purity using Specimens from a Private 
Laboratory 
 
PL1 and PL3: microscopically positive for C. parvum in a private laboratory. PL2 and PL4: 
microscopically positive for G. lambliae in a private laboratory. These specimens were used to 
obtain control DNA. * An additional step prior to DNA extraction which included adding 180 
µl of ATL buffer and 20 µl of proteinase K to the stool specimens and placing this in a 56°C 
water bath for 3 hours. DNA refers to the DNA concentration that is measured in nanograms 
per microliter. The purity of DNA was calculated using the 260/280 ratio. ND represents 
specimens that were not done. 
 









Protocol A: 100°C lysis 0.4 0.55 2.6 3.39 ND ND ND ND
Protocol A with an additional step* 0.4 1.28 1.8 2.26 ND ND ND ND
Protocol A with silica beads 0.3 3.7 0.78 0.2 ND ND ND ND
Protocol C 3.9 3.05 6 2.7 7.8 1.77 10 1.58
Protocol D 5.7 2.18 6.3 2.35 15.9 2.14 17 2.24
Protocol D: concentrated stool ND ND ND ND 0.6 0.99 0.8 0.72
Protocol D: silica beads ND ND ND ND 6.2 1.8 0 0
PL4PL1 PL2 PL3
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Chapter Five: Discussion 
 
The Ziehl-Neelsen stain in its classic or modified form is usually employed for the 
detection of acid fast microbes. With this staining technique, it is also possible to detect 
non-acid fast microbes, which take on the counter stain. Coccidian oocysts stain red against 
a blue background (Samie et al.,2009). The modified trichrome stain is known to detect 
various protozoa which stain reddish-purple against a dark green or blue background 
(Shoaib, 2002). The modified Ziehl-Neelsen and the modified trichrome stains were 
applied in the detection of protozoa listed in Table 2.1. 
 
 The key intestinal parasites causing diarrhoea in children aged 0-5 years in the eThekwini 
district of KZN were identified by microscopy as Giardia lambliae and Cryptosporidium 
parvum (Table 4.1.). Both the modified Ziehl-Neelsen and the modified trichrome staining 
technique, detected a higher number of C. parvum as compared to G. lambliae. According 
to the Chi-Square Pearson’s test, the higher number of C. parvum detected in comparison 
to G. lambliae, was statistically significant (p<0.05).  Only two patients were found to be 
co-infected with both C. parvum and G. lambliae when both staining techniques were used. 
 
 With the modified trichrome stain, G. lambliae trophozoites appeared red. The nuclei, 
axostyle and flagellum of the pear-shaped trophozoite can be clearly seen in Figure 4.1.1. 
Since cysts of, G. lambliae are not acid-fast, those identified by means of the modified 
Ziehl-Neelsen staining technique, stained blue as part of the background stain (Fig 4.1.3). 
C. parvum oocysts stained red with the modified Ziehl-Neelsen stain (Fig 4.1.2.) and with 
the modified trichrome stain.  
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In Ethiopia Adamu et al (2006) had found a prevalence of 6.3% for G. lambliae and Ansari 
et al (2012), also reported a similar prevalence in Kathmandu, India, of 3.4%, which is 
concordant with the findings of our study. A study by Wellington et al (2008) in Nigeria, 
reported a prevalence of 27.6% and 4.8% for C. parvum and G. lambliae respectively, 
these findings correlate well with the results in this study. Our results for Cryptosporidium 
are also in agreement with Samie et al (2009) in the Limpopo province of South Africa, 
who had found C. parvum to be prevalent in 25% of hospital attendees experiencing 
diarrhoea. 
 
 For most of the patients enrolled in this study, no protozoal parasite was detected in stool 
specimens. This could be attributed to one specimen being collected, instead of multiple 
stool specimens (Adamu et al., 2006).  Parasites are shed intermittently (Adamu et al., 
2006); hence at least three stool specimens should be collected on three different days. 
However, this was not possible in this study as collecting quality stool specimens from 
these young children was quite challenging. Furthermore, most children were outpatients 
and not available for repeat specimen collection. Parents were also not keen on the 
collection of more than one specimen from their child. Non-protozoal causes of the 
diarrhoea provide another explanation for these negative findings. 
 
Cryptosporidium detection requires the presence of 50 000 – 500 000 oocysts per gram of 
stool (Tahvildar-Biderouni and Salehi, 2014). To achieve this in as many specimens as 
possible, concentration of stool specimens is advised prior to staining with the modified 
Ziehl-Neelsen method. This increases the accuracy for detecting Cryptosporidium in stool 
specimens (Tahvildar-Biderouni and Salehi, 2014).  In this study we did not concentrate 
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stool prior to staining, as the amount of stool specimens collected from most children, was 
insufficient to perform formol-ether concentration. Hence it is possible that we may have 
missed a significant proportion of entero-pathogenic protozoa during microscopic 
examination. 
  
Children under two years were the most affected by C. parvum and G. lambliae as 
compared to those children that were between the ages of two-five years (Table 4.1.2.). 
Our study concurs with the findings of Ansari et al (2012), who reported diarrhoea in 
69.9% of children less than 2 years. The high prevalence of protozoal infection in children 
under the age of 2 years in our study could be attributed to formula feed or mixed feed 
milk. Formula fed infants could be ingesting milk that contains parasites, since 
contaminated water and unhygienic habits may be used in the preparation of milk (Black et 
al., 1982).Infants that are breastfed are protected against severe diarrhoea by maternal 
antibodies. Adequate acquisition of immunity only occurs between 12-16 months of age 
(Ansari et al., 2012).   
 
There were more females infected with C. parvum and G. lambliae than there were males 
(Table 4.1.3.), although this did not reach statistical significance (p>0.05). Of all the 
children infected with C. parvum, a third of them was positive for HIV and had a history of 
exposure to HIV (Table 4.1.4.). The HIV status of Cryptosporidium infected individuals 
correlates well with other studies that have indicated an association between HIV and C. 
parvum. However, there were more Cryptosporidium positive children that were HIV 
negative as compared to those that were HIV positive. This could be due to the weak 
immune system of infants which is still developing. In addition, Cryptosporidium is an 
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entero-pathogen capable of infecting both immune competent and immune compromised 
hosts (Table 2.1.). Therefore children in this study that harboured C. parvum, were 
immune-competent. None of the children infected with G. lambliae were HIV positive or 
had a history of exposure, hence there was no association between HIV and G. lambliae 
infection in this study. 
 
 The majority of the children infected with C. parvum and/ or G. lambliae used water from 
a communal tap (Table 4.1.5.). However G. lambliae cysts and C. parvum oocyst are 
resilient and have the ability to resist chlorination and may still be present in treated water 
(deRegnier et al., 198 , Johns et al., and 1995 Chauret et al., 1995).  Improper sanitation 
habits facilitate the transmission of entero-pathogenic protozoa. In this study the majority 
of the caregivers had reported the use of flush toilets in their households (Table 4.1.6.). 
However, that does not necessarily correlate with good hand hygiene. 
 
More children infected with both C. parvum and G. lambliae had diarrhoea for one to three 
days as shown in Table 4.1.7. This suggests most children had acute diarrhoea even though 
a considerable amount of the infected children were either HIV positive or had a history of 
exposure to HIV. Some children that were infected with C. parvum suffered from 
malnutrition with signs of kwashiorkor (Table 4.1.8). This was not the case with those 
infected with G. lambliae. However, the numbers are small. Akingbade et al (2013) 
indicated that malnutrition may also be listed as a cause of death in patients with diarrhoea. 
This is because diarrheic patients eat less; therefore they have a reduced ability to absorb 
nutrients essential for their survival. 
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Bright field microscopy is used in many laboratories; however the inability to detect low 
numbers of oocysts and cysts of C. parvum and G. lambliae respectively, makes it less 
sensitive than other diagnostic techniques (Johnston et al., 2003). PCR is considered more 
sensitive and specific than microscopy (Morgan et al., 1998) with a reported sensitivity of 
100% (Elsafi et al., 2013). Hence it was used in this study in an attempt to confirm the 
microscopic observations. 
 
Extracting DNA from stool specimens posed  a challenging task. Various DNA extraction 
methodologies were tried, tested and manipulated.  However none worked. Extraction 
methodologies were tried on microscopically positive specimens (Tables 4.2.1, 4.2.2 and 
4.2.3) but none of the extraction products shown in table 4.2.1 were acceptable for use with 
PCR.  In table 4.2.3 the protocol for tissue specimens produced DNA extracts of sufficient 
quantity and quality; however PCR was unsuccessful as the presence of primer dimers and 
the absence of a product were observed (Fig 4.2.2.).  
 
We considered three possible reasons for the lack of success. The specimens we used may 
not have been true positives, the storage at – 20
o
C could have negatively impacted or the 
cyst and oocyst walls could be too strong to lyse with the methods employed. To address 
the first two possibilities we used specimens kindly provided by one of the private 
laboratories in Pretoria. These specimens were fresh and were microscopically confirmed 
positive for C. parvum and G. lambliae, respectively by experienced technologists. 
However, only the protocol for tissue specimens produced acceptable DNA (Table 4.2.4). 
PCR performed remained unsuccessful for both protozoal species, suggesting that the 
harshness of the cyst walls was the problem.  
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The QIAamp DNA Mini kit was tried (Table 4.2.3) since the protocol contained lysis steps 
that in essence were similar to the stool kit protocol, with just one or two variations. Both 
the protocols for extraction from blood specimens and tissue specimens were tried. Silica 
beads (Table 4.2.4) were incorporated into the extraction protocols to mechanically disrupt 
the oocysts and cysts of C. parvum and G. lambliae, respectively. One extract produced 
low concentration but sufficient purity whilst the other specimens produced insufficient 
quality and quantity of DNA. 
 
The CTAB DNA extraction method was tried since it is used to get DNA out of 
Mycobacterium tuberculosis, which is also a difficult organism to extract DNA from. 
Hence it was assumed that it may work on the robust C. parvum oocysts. The formol-ether 
concentration was performed prior to DNA extraction with the CTAB and tissue specimen 
protocols (protocols C and D, tables 4.2.2 and 4.2.4, respectively). Sufficient stool was 
present in specimens that underwent formol-ether concentration. This was not successful 
(Table 4.2.2 and Table 4.2.4). 
 
Hawash (2014) modified the manufacturer’s protocol for use with the QIAamp Stool Mini 
kit (Qiagen, Hilden, Germany) since their application of the manufacturer’s protocol 
produced a faint PCR band for C. parvum. The modification made was lysis at 100
o
C for 
10 minutes. This modification resulted in a clear bright band when PCR was performed. 
However when the same modification was implemented with the Qiagen protocol in our 
study (Table 4.2.4.), the DNA extract was of poor concentration and purity. A study 
conducted by Moore et al (2016) had also reported modifications to the QIAamp Stool 
Mini kit. These modifications included 5 cycles of freezing and thawing as well as heating 
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and cooling to weaken the oocyst wall of Cryptosporidium. This was done in order to 
increase the yield of DNA extracts. This suggests that the QIAamp Stool Mini kit is 
inefficient for the extraction of DNA from entero-pathogenic protozoa, since the yield of 
DNA is low. The modifications by Moore et al (2016) had only been published after 
laboratory work for this study was completed, therefore we could not have tried these 
modifications to the QIAamp Fast DNA Mini kit. 
 
The complexity of the oocyst wall described in chapter 2.4.3.2 could have been the primary 
reason for unsuccessful PCR. The DNA obtained may have been from other miro-
organisms. Various treatment procedures targeting digestion of the oocyst wall of C. 
parvum were investigated by Harris and Petry (1999). Their findings suggest that 
proteinase K is most effective in the digestion of the oocyst wall. Trypsin was also 
effective in digesting the oocyst wall of C. parvum while, pepsin was the least effective. In 
addition, ultra-sonication and phenol-chloroform extraction proved not to be effective in 
lysing the oocyst wall. All DNA extraction techniques used in the study presented in this 
dissertation included proteinase K, however it is possible that an insufficient amount, could 
have prevented digestion of the oocyst wall. The amount of proteinase K used was 
according to the recommendations supplied by the manufacturer of the kits. 
 
Low PCR efficacy on specimens that had good purity and sufficient quantity could have 
been affected by the presence of inhibitors such as bilirubins, bile salts, heme and 
carbohydrates in the faecal specimen (Oikarinen et al., 2009). Inhibitors interfere with the 
reaction between DNA and DNA polymerase (Tsai and Rochelle, 2001) if co-extracted 
with the DNA (Schrader et al., 2012). Amplification of nucleic acids can also be inhibited 
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by unsuccessful lysis of the oocysts and degradation of nucleic acids (Carey et al., 2004), 
which could possibly also have been the case in this study when finally DNA of sufficient 
quantity and quality was used.  
 
A recent study in Cambodia, investigating the various species and subtypes of 
Cryptosporidium, demonstrated evidence of both anthroponotic and zoonotic transmission. 
In addition the authors found multiple species of Cryptosporidium involved in causing 
diarrhoea among children below 16 years of age. The different species of Cryptosporidium 
causing diarrhoea included; C. hominis, C. melagridis, C. parvum, C. canis, C. suis and C. 
ubiquitum. C. hominis was the highest cause of diarrhoea, followed by C. melagridis and 
then C. parvum. C. canis, C. suis and C. ubiquitum were present in one stool specimen, 
respectively. Furthermore, the authors also indicated that 50% of C. parvum infected 
children had C. parvum with subtype IIeA7G1 present. This subtype is rare, with only a 
single strain being previously described in India (Moore et al., 2016). The possibility of 
other species and subtypes of Cryptosporidium present in KwaZulu-Natal, South Africa, 
cannot be excluded. Since these findings demonstrate that various species and subtypes 
exist. This could be a possible reason for the unsuccessful PCR described in this 
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Chapter Six: Conclusion 
This study investigated the role of entero-pathogenic protozoa in causing diarrhoea in 
children between the ages of 0-5 years. The species found were Cryptosporidium parvum 
and Giardia lambliae. Of these parasites, Cryptosporidium parvum demonstrated a higher 
prevalence than Giardia lambliae. Giardia lambliae infection has been strongly associated 
with children under the age of five that attend day care centres in KZN. However our study 
demonstrates a stronger association between C. parvum infection and children under the 
age of five. C. parvum is known to infect both the immune compromised and immune 
competent host. This study reports that diseases other than HIV infection could have 
impacted on the immunity of parasite-infected children. Children experiencing diarrhoea 
should also have their stool examined for parasites, in addition to bacteria and viruses, 
which are not always done, hence intestinal parasites are missed, and continue to 
proliferate among children in the eThekwini district of KZN. 
 
Apart from microscopy, PCR diagnosis was tried but this was unsuccessful. Microscopy is 
known to be less sensitive than PCR, but highly specific if verified by an independent, 
experienced laboratory technician. Most laboratories in developing countries continue to 
use microscopy in the diagnosis of intestinal parasitic infections. Even though a substantial 
amount of evidence highlights the insensitivity of this technique. This is because reliable 
techniques such as PCR are expensive and require special equipment as well as skilled 
laboratory workers. Furthermore, conducting PCR on stool specimens aimed at targeting 
intestinal parasites remains a challenge as indicated in this dissertation. 
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With the collection of multiple stool specimens, incorporation of suitable concentration 
techniques, observations by an experienced microscopist and quality control conducted by 
an independent laboratory technologist, microscopy can still be used as a diagnostic tool 
for the identification of intestinal parasites. This study was limited to a study population of 
children from one hospital in KZN and is therefore not representative of the entire 
population of children in KZN. Future studies should aim to investigate multiple cohorts of 
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Appendix 3: Study Information  
 
Information to Patients 
 
 
Title: Surveillance for Diarrhoeal Pathogens in Children 5 years and below in KZN 
 
 
We are a team of doctors, nurses and scientists. My name is………………. and I work in 
the Department of Infection Prevention and Control, University of KwaZulu-Natal / King 
Edwards Hospital. We are involved in conducting healthcare associated research for the 
KwaZulu-Natal Department of Health so that we may better understand diarrhoeal disease. 
Diarrhoea is one of the most common causes of illness and death in children aged 5 years 
and below. Diarrhoea can be caused by germs that are passed to a child through food or 
water or from other people.    
 
At the moment we are studying what causes diarrhoea and which medicines will best treat 
it. This is in order to improve treatment as well as learn better ways to prevent this illness. I 
invite you to consider allowing your child/ward to participate in this study that involves 
children 5 years and below with diarrhoea. Your child/ward having diarrhoea means that 
he/she has passed three or more loose, liquid or watery stools or at least one bloody loose 
stool than normal within a day. In order to treat your child/ward for this illness, sometimes 
a stool specimen and blood specimen is taken.  
There is also a question on whether you know the HIV status of your child/ward. You may 
choose not to answer this question if you feel uncomfortable doing this. If you do not know 
your child’s HIV status and you want to know, we can request that, an HIV test is done by 
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the doctor treating your child. This is to better manage the disease. If you do not want to 
know the HIV status of your child/ward, then we do not have to test him/her. However you 
may also agree that we can take your child’s/ward’s blood for HIV testing, but we will not 
disclose his/her result to anyone, but use it for the study only.  
 
The care that your child receives will not, be affected by you agreeing or refusing to take 
part in the study. The people working on this study are separate from the staff at this 
clinic/hospital.  
 
All the information that we get from you on behalf of your child/ward will be kept 
confidential at all times. If you agree to take part in the study your child will be given a 
study number. Only this study number will be used on study records and blood/stool 
samples, therefore people working in the laboratory or people looking at your child/ward 




The nurse will assist in collecting the stool specimen into a leak-proof clean dry container. 
A teaspoon of blood specimen will also be collected into a tube from your child/ward. The 
stool specimen will be sent to test for the presence of common germs. We will test his/her 
blood for Antibody levels against Rotavirus and other germs. Taking these specimens will 
not harm your child/ward in any way, but he/she may experience minor discomfort.  




You will be required to spend about 30 minutes of your time in the clinic/hospital so that 
we will be able to interview you and collect these specimens from your child/ward. Taking 
part in the study will not put your child/ward at any risk. The participation of your 
child/ward will benefit us in understanding the causes of diarrhoea and knowing the best 
treatment for children like your child/ward. If the findings from our laboratory 
investigations require an additional treatment for your child/ward condition we will inform 
the doctor treating your child. If your doctor feels that it is necessary he/she will contact 
you personally so that your child/ward can be treated with a new medication. This might 
cost you one extra visit to the clinic/hospital.  
 
You will not receive any money for agreeing to allow your child/ward to participate in this 
study.  
 
If you agree to allow your child/ward participate in this study, we require that you sign a 
form which gives us permission to: 
 Interview you and record data on an information sheet 
 Collect specimens from your child/ward for laboratory tests 
 Get your child’s/ward’s HIV status from you (not compulsory) 
This study has been ethically reviewed and approved by the UKZN Biomedical research 
Ethics Committee (approval number………….). In the event of any problems or 
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concerns/questions you may contact Prof P Moodley or the UKZN Biomedical Research 
Ethics Committee, contact details as follows:  
 
Prof P Moodley 
Chief Specialist: Infection Prevention and Control 
KwaZulu-Natal Department of Health 
Medical Microbiology and Infection Control 
University of KwaZulu-Natal 




BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: +27-31-2604769 - Fax: +27-31-2604609 
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Email: BREC@ukzn.ac.za  
 
Do you have any questions or do you need clarity on any aspect? 
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Appendix 4: Questionnaire 
 
Patient no.      
Date of birth (dd/mm/yy)       
Date of admission       









Age    
Gender            
Weight  kg   centile 
Height   cm   centile 
Temp   C 
 
HIVstatus On ART? 
CD4 count/percentage  
  
 
How long does the patient have diarrhoea for?  
Is the child underweight for age ° 
Does the child have kwashiorkor ° 
 
 
Has the child received all immunizations to date: 
                        Vaccine                   Date received 
Birth BCG  
  
6 wks OPV  




Hep B (1)  
PCV ( J)  
10 wks DTaP-I 
PV/Hib  (2) 
 
Hep B (2 )  
14 wks RV (2)  
DTaP - I 
PV/Hib (3) 
 
Hep B (3)  
PCV (2)  
P N Exposed Unexposed Unknown 










Measles (1)  




Measles 2)  
 
How many doses has of vitamin A has the child received    
 















If child <6 months, is the child 
exclusively breastfed  
formula-fed  















                                                                   Specify ________________ 
 
Piped water in dwelling  
Piped water on site  
Neighbour's tap  
Communal tap  
Rainwater  
Borehole on site  
Borehole off site  
  
Dam/pool/stagnant  water  
Well  
Spring         
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Type of sanitation 
 
 
Specify   __________ 
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The study has been explained to me in detail and I grant permission for stool specimen to 
be collected from my child/ward. The stool specimen will be examined for germs causing 
diarrhoea and medicines that may kill these germs. 
 
Yes........... No................. 
I give permission for the doctor/nurse to record the HIV status of my child/ward on the 
information sheet and I understand that this information will not be linked to my his/her 
name. 
 
Yes............      No................... 
I grant permission for a blood specimen to be collected from my child/ward and examined 
for HIV and antibody levels against some germs that cause diarrhoea.   
 
Yes........... No................. 
Name of Parent/Guardian:      Name of Doctor/Nurse 
 
--------------------------------------                     --------------------------------- 
 




Name of Translator (if applicable) 
 





NB: This sheet is to be removed by the study co-ordinator upon completion of enrolment and delivered in a sealed 
envelope to the principal investigator. The forms will be stored in a separate, locked cabinet and destroyed when the 
study is officially closed 
 
